Over the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment for patients with advanced lung cancer, helping many live longer lives and improving overall survival for the disease. However, ...
Jun 4, 2023
0
61
The federal government is reconsidering a decision that breast cancer patients, plastic surgeons, and members of Congress have protested would limit women's options for reconstructive surgery.
Jun 1, 2023
0
39
The first successful in-patient trial of liver dialysis has been completed by researchers from UCL, the Royal Free Hospital, UCL spin-out Yaqrit and their collaborators.
May 31, 2023
0
12
Worldwide, one of the initial responses to the COVID-19 virus was locking down parts of the economy to reduce social interactions and the virus's spread. Now, the development and production of vaccines have largely replaced ...
May 30, 2023
0
4
Tobacco use imposes a large health and economic burden worldwide. Research estimates that, in 2019, about 8 million deaths were attributable to tobacco smoking. Tobacco also reduces years of healthy living: about 200 million ...
May 30, 2023
0
2
A new distributional cost-effectiveness analysis of gene therapy versus standard-of-care for sickle cell disease (SCD) found that while gene therapy is cost-ineffective by conventional measures, it can be an equitable therapeutic ...
May 29, 2023
0
4
In this systematic review, the authors summarized the wide range of peer-reviewed literature that links continuity of the doctor-patient relationship to health care costs and care utilization. This information is important ...
May 23, 2023
0
2
Researchers from Iceland trained a machine learning model with artificial intelligence to triage patients with respiratory symptoms before the patients visit a primary care clinic.
May 23, 2023
0
4
A cost-effectiveness analysis of screening for chronic kidney disease (CKD) has found that screening all adults in the United States starting at age 35 could be cost-effective for the quality of life-years (QALY) gained. ...
May 22, 2023
0
2
The Alzheimer's Association is stepping up public pressure on the Biden administration, hoping to convince the government to pay for a new class of promising but expensive Alzheimer's drugs.
May 18, 2023
0
13
